Aigen Investment Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $149K | Buy |
+10,662
| New | +$149K | 0.02% | 689 |
|
|
2023
Q3 | – | Sell |
-19,594
| Closed | -$578K | – | 887 |
|
|
2023
Q2 | $578K | Buy |
+19,594
| New | +$578K | 0.09% | 313 |
|
|
2023
Q1 | – | Sell |
-10,751
| Closed | -$299K | – | 668 |
|
|
2022
Q4 | $299K | Buy |
+10,751
| New | +$299K | 0.04% | 364 |
|
|
2021
Q3 | – | Sell |
-3,243
| Closed | -$254K | – | 522 |
|
|
2021
Q2 | $254K | Sell |
3,243
-322
| -9% | -$25.2K | 0.04% | 354 |
|
|
2021
Q1 | $204K | Buy |
+3,565
| New | +$204K | 0.03% | 539 |
|
|
2020
Q4 | – | Sell |
-12,877
| Closed | -$461K | – | 831 |
|
|
2020
Q3 | $461K | Buy |
+12,877
| New | +$461K | 0.06% | 420 |
|
|
2020
Q1 | – | Sell |
-2,982
| Closed | -$52K | – | 1326 |
|
|
2019
Q4 | $52K | Buy |
+2,982
| New | +$52K | 0.01% | 801 |
|